NO855051L - Fremgangsmaate for fremstilling av l-carnitin. - Google Patents
Fremgangsmaate for fremstilling av l-carnitin.Info
- Publication number
- NO855051L NO855051L NO855051A NO855051A NO855051L NO 855051 L NO855051 L NO 855051L NO 855051 A NO855051 A NO 855051A NO 855051 A NO855051 A NO 855051A NO 855051 L NO855051 L NO 855051L
- Authority
- NO
- Norway
- Prior art keywords
- carnitine
- microorganism
- medium
- bacterium
- atcc
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 55
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title claims abstract description 46
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- PHIQHXFUZVPYII-UHFFFAOYSA-N carnitine Chemical compound C[N+](C)(C)CC(O)CC([O-])=O PHIQHXFUZVPYII-UHFFFAOYSA-N 0.000 claims abstract description 28
- 244000005700 microbiome Species 0.000 claims abstract description 27
- PHIQHXFUZVPYII-LURJTMIESA-N (S)-carnitine Chemical compound C[N+](C)(C)C[C@@H](O)CC([O-])=O PHIQHXFUZVPYII-LURJTMIESA-N 0.000 claims abstract description 16
- 230000008569 process Effects 0.000 claims abstract description 10
- 239000012429 reaction media Substances 0.000 claims abstract description 7
- 239000002609 medium Substances 0.000 claims description 50
- 241000588624 Acinetobacter calcoaceticus Species 0.000 claims description 30
- 241000894006 Bacteria Species 0.000 claims description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 238000000855 fermentation Methods 0.000 claims description 12
- 230000004151 fermentation Effects 0.000 claims description 12
- 229960004203 carnitine Drugs 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 230000004060 metabolic process Effects 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 2
- 241000589291 Acinetobacter Species 0.000 claims 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 210000001822 immobilized cell Anatomy 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 claims 1
- 238000009825 accumulation Methods 0.000 abstract description 4
- JXXCENBLGFBQJM-UHFFFAOYSA-N (3-carboxy-2-hydroxypropyl)-trimethylazanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC(O)CC(O)=O JXXCENBLGFBQJM-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- 230000012010 growth Effects 0.000 description 11
- 229920001817 Agar Polymers 0.000 description 10
- JXXCENBLGFBQJM-FYZOBXCZSA-N [(2r)-3-carboxy-2-hydroxypropyl]-trimethylazanium;chloride Chemical compound [Cl-].C[N+](C)(C)C[C@H](O)CC(O)=O JXXCENBLGFBQJM-FYZOBXCZSA-N 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 238000002703 mutagenesis Methods 0.000 description 7
- 231100000350 mutagenesis Toxicity 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000469 ethanolic extract Substances 0.000 description 5
- JXXCENBLGFBQJM-RGMNGODLSA-N (3s)-3-hydroxy-4-(trimethylazaniumyl)butanoate;hydrochloride Chemical compound [Cl-].C[N+](C)(C)C[C@@H](O)CC(O)=O JXXCENBLGFBQJM-RGMNGODLSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229960000678 carnitine chloride Drugs 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000010865 sewage Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- ZGONASGBWOJHDD-UHFFFAOYSA-N 1-ethyl-2-nitro-1-nitrosoguanidine Chemical compound CCN(N=O)C(N)=N[N+]([O-])=O ZGONASGBWOJHDD-UHFFFAOYSA-N 0.000 description 1
- CBSVRLFKJUFKSN-UHFFFAOYSA-N 2-(methylamino)-1-nitroso-7h-purin-6-one Chemical compound O=C1N(N=O)C(NC)=NC2=C1NC=N2 CBSVRLFKJUFKSN-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- -1 8-asaguanine Chemical compound 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- UKFWSNCTAHXBQN-UHFFFAOYSA-N ammonium iodide Chemical class [NH4+].[I-] UKFWSNCTAHXBQN-UHFFFAOYSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
- 229960004961 mechlorethamine Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000008684 selective degradation Effects 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/001—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60228984A | 1984-04-20 | 1984-04-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO855051L true NO855051L (no) | 1985-12-16 |
Family
ID=24410766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO855051A NO855051L (no) | 1984-04-20 | 1985-12-16 | Fremgangsmaate for fremstilling av l-carnitin. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0179864B1 (es) |
| JP (1) | JPH0714355B2 (es) |
| KR (1) | KR860700045A (es) |
| AU (1) | AU4233285A (es) |
| CA (1) | CA1269941A (es) |
| DE (1) | DE3579284D1 (es) |
| ES (1) | ES8606497A1 (es) |
| FI (1) | FI855074A (es) |
| GR (1) | GR850950B (es) |
| MX (1) | MX7657E (es) |
| NO (1) | NO855051L (es) |
| PH (1) | PH24045A (es) |
| PT (1) | PT80323B (es) |
| WO (1) | WO1985004900A1 (es) |
| YU (1) | YU69785A (es) |
| ZA (1) | ZA852808B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1338723C (en) * | 1985-11-25 | 1996-11-19 | Hideyuki Takahashi | Process for preparing 3-chloro-1,2-propanediol |
| JPS63251098A (ja) * | 1987-04-07 | 1988-10-18 | Kanegafuchi Chem Ind Co Ltd | （ｒ）−３−ハロゲノ−１，２−プロパンジオ−ルの製造法 |
| JPH0669381B2 (ja) * | 1987-12-04 | 1994-09-07 | 協和醗酵工業株式会社 | カルニチンの製造法 |
| DE4106375A1 (de) * | 1991-02-28 | 1992-09-03 | Degussa | Eine l-carnitin-amidase produzierender mikroorganismus, l-carnitin-amidase, verfahren zu deren gewinnung und deren verwendung |
| DE10260456A1 (de) * | 2002-12-18 | 2004-07-08 | Ufz-Umweltforschungszentrum Leipzig-Halle Gmbh | Mutanten des Bakterienstammes Delftia acidovorans MC1 und deren Verwendung zur Produktion von hochreinen R-Enantiomeren von 2-Phenoxypropionsäure-Derivaten |
| CN114181101A (zh) * | 2021-11-26 | 2022-03-15 | 开原亨泰营养科技有限公司 | 能够控制产品晶型的左旋肉碱酒石酸盐的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3600279A (en) * | 1970-06-01 | 1971-08-17 | Takeda Chemical Industries Ltd | Method for producing d-pantoic acid |
| US3912592A (en) * | 1974-05-06 | 1975-10-14 | Hoffmann La Roche | Method for producing L-sorbosone |
| FR2398046A1 (fr) * | 1977-07-18 | 1979-02-16 | Inst Francais Du Petrole | Synthese enzymatique de la l-carnitine |
| IT1142201B (it) * | 1980-06-24 | 1986-10-08 | Sigma Tau Ind Farmaceuti | Procedimento per la produzione enzimatica di l-carnitina |
-
1985
- 1985-04-15 ZA ZA852808A patent/ZA852808B/xx unknown
- 1985-04-16 CA CA000479269A patent/CA1269941A/en not_active Expired - Lifetime
- 1985-04-17 DE DE8585902288T patent/DE3579284D1/de not_active Expired - Lifetime
- 1985-04-17 WO PCT/US1985/000674 patent/WO1985004900A1/en active IP Right Grant
- 1985-04-17 JP JP60501876A patent/JPH0714355B2/ja not_active Expired - Lifetime
- 1985-04-17 AU AU42332/85A patent/AU4233285A/en not_active Abandoned
- 1985-04-17 EP EP85902288A patent/EP0179864B1/en not_active Expired - Lifetime
- 1985-04-18 GR GR850950A patent/GR850950B/el unknown
- 1985-04-19 ES ES542411A patent/ES8606497A1/es not_active Expired
- 1985-04-19 MX MX85963U patent/MX7657E/es unknown
- 1985-04-19 PH PH32168A patent/PH24045A/en unknown
- 1985-04-19 PT PT80323A patent/PT80323B/pt unknown
- 1985-04-24 YU YU00697/85A patent/YU69785A/xx unknown
- 1985-12-16 NO NO855051A patent/NO855051L/no unknown
- 1985-12-18 FI FI855074A patent/FI855074A/fi not_active Application Discontinuation
- 1985-12-19 KR KR1019850700396A patent/KR860700045A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0714355B2 (ja) | 1995-02-22 |
| FI855074A0 (fi) | 1985-12-18 |
| FI855074A (fi) | 1985-12-18 |
| ES542411A0 (es) | 1986-04-01 |
| GR850950B (es) | 1985-07-16 |
| PT80323B (en) | 1986-11-13 |
| CA1269941C (en) | 1990-06-05 |
| WO1985004900A1 (en) | 1985-11-07 |
| KR860700045A (ko) | 1986-01-31 |
| EP0179864A4 (en) | 1987-01-20 |
| CA1269941A (en) | 1990-06-05 |
| YU69785A (en) | 1987-12-31 |
| ES8606497A1 (es) | 1986-04-01 |
| PT80323A (en) | 1985-05-01 |
| EP0179864A1 (en) | 1986-05-07 |
| EP0179864B1 (en) | 1990-08-22 |
| AU4233285A (en) | 1985-11-15 |
| PH24045A (en) | 1990-03-05 |
| MX7657E (es) | 1990-06-12 |
| ZA852808B (en) | 1985-11-27 |
| JPS61501886A (ja) | 1986-09-04 |
| DE3579284D1 (de) | 1990-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yoshida et al. | Production of ubiquinone-10 using bacteria | |
| US5378616A (en) | Mutant Escherichia coli capable of enhanced L-glutamic acid production by fermentation | |
| AU602376B2 (en) | Process for production of eicosapentaenoic acid | |
| JPH03232497A (ja) | 発酵法によるｌ―グルタミンの製造方法 | |
| EP0939831A1 (en) | Novel bacterial strains and use thereof in fermentation processes for 2-keto-l-gulonic acid production | |
| Yang et al. | Production of erythritol from glucose by an osmophilic mutant of Candida magnoliae | |
| JP3046332B2 (ja) | 発酵法によるアミノ酸の製造法 | |
| NO855051L (no) | Fremgangsmaate for fremstilling av l-carnitin. | |
| CA1040565A (en) | D-ribose production by bacillus | |
| US6335177B1 (en) | Microorganisms and method for producing xylitol or d-xylulose | |
| US4751182A (en) | Process for preparing L-carnitine from DL-carnitine | |
| US4892823A (en) | Method for producing 2-keto-L-gulonic acid | |
| EP0386476B1 (en) | Process for producing L-alanine | |
| DK172133B1 (da) | Fremgangsmåde til fremstilling af L-sorbose | |
| JPH06133790A (ja) | ビオチンの製造方法および使用される微生物 | |
| CA1336414C (en) | D-amidase and process for producing d--alanine and/or l--alanineamide | |
| WO1998048033A1 (en) | STRAIN PRODUCING REMARKABLE AMOUNT OF ε-POLY-L-LYSINE AND PROCESS FOR PRODUCING ε-POLY-L-LYSINE BY USING THE SAME | |
| WO1989000201A1 (en) | Production of organic compounds | |
| EP0567644B1 (en) | Process for producing l-alanine by fermentation | |
| US5496715A (en) | Process for preparing indigo | |
| US4528273A (en) | Microorganism strains for the fermentative preparation of L-serine | |
| AU603339B2 (en) | Process for the production of sorbitol by enzymatic reaction, and microorganisms suitable for the purpose | |
| JP4087919B2 (ja) | ｄ−ビオチンの発酵による製造 | |
| JP3036819B2 (ja) | 芳香族アミノ酸の製造法 | |
| Hong et al. | A 3, 5-diaminohexanoate-decomposing Brevibacterium |